![](/img/cover-not-exists.png)
18LBA A GCIG randomized phase III study of carboplatin (C) & pegylated liposomal doxorubicin (PLD) (C-D) vs carboplatin (C) & paclitaxel (P) (C-P): CALYPSO results in partially platinum-sensitive ovarian cancer (OC) patients
P. Vasey, R. Largillier, M. Gropp, V. Gebski, R. Sandvei, L. Elit, L. Angleitner-Boubezinek, N. Reed, S. Pignata, A.M. FerreroVolume:
7
Year:
2009
Language:
english
DOI:
10.1016/s1359-6349(09)72053-1
File:
PDF, 49 KB
english, 2009